Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neural Therapeutics Inc. ( (TSE:NURL) ) just unveiled an announcement.
Neural Therapeutics Inc. has announced the expansion of its portfolio company, Hanf.com, into northern Germany with the opening of two new stores in Bielefeld and Herford. This strategic move aims to enhance Hanf.com’s brand visibility and revenue growth by integrating established CBD retail businesses into its network, which now includes 19 locations across Germany. The expansion is part of Neural’s broader strategy to increase its commercial footprint in Europe while continuing its core focus on drug discovery and mental health innovation.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company that focuses on developing therapeutic solutions for mental health conditions related to substance use disorders, such as alcohol and opioid dependence. The company employs innovative approaches, including the use of sub-hallucinogenic doses of mescaline extract, to enhance safety and scalability while maintaining therapeutic efficacy.
Average Trading Volume: 315,804
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$1.61M
See more insights into NURL stock on TipRanks’ Stock Analysis page.